| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Neuroblastoma, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Neuroblastoma, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 1 +1 more | |
| | | Single nucleotide variant (missense variant) | Charcot-Marie-Tooth disease type 2 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Charcot-Marie-Tooth disease type 2 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +2 more | |
| | | Single nucleotide variant (missense variant) | Charcot-Marie-Tooth disease type 2 +2 more | |
| | | Single nucleotide variant (missense variant) | Charcot-Marie-Tooth disease type 2 +4 more | |
| | | Single nucleotide variant (intron variant) | Charcot-Marie-Tooth disease +4 more | |
| | | Single nucleotide variant (intron variant) | Charcot-Marie-Tooth disease +4 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | not specified +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 1 | |